000705 浙江震元
已收盘 04-27 15:00:00
资讯
新帖
简况
浙江震元:震元生物结合销售需求正常生产中
证券之星 · 04-22
浙江震元:震元生物结合销售需求正常生产中
浙江震元最新公告:董事、副总经理魏民被留置调查
证券之星 · 04-17
浙江震元最新公告:董事、副总经理魏民被留置调查
浙江震元:公司S1产线的产品国内目前使用客户有医美、食品等行业
证券之星 · 04-16
浙江震元:公司S1产线的产品国内目前使用客户有医美、食品等行业
浙江震元:华润震元自2025年2月起不再纳入公司合并财务报表范围
证券之星 · 03-30
浙江震元:华润震元自2025年2月起不再纳入公司合并财务报表范围
浙江震元:公司合成生物S1产线自正式投产以来,产能结合销售需求逐步释放
证券之星 · 03-25
浙江震元:公司合成生物S1产线自正式投产以来,产能结合销售需求逐步释放
股市必读:浙江震元(000705)3月23日收盘跌7.1%,主力净流出705.19万元
证券之星 · 03-24
股市必读:浙江震元(000705)3月23日收盘跌7.1%,主力净流出705.19万元
股市必读:浙江震元(000705)3月13日董秘有最新回复
证券之星 · 03-16
股市必读:浙江震元(000705)3月13日董秘有最新回复
股市必读:浙江震元(000705)3月10日董秘有最新回复
证券之星 · 03-11
股市必读:浙江震元(000705)3月10日董秘有最新回复
浙江震元:公司合成生物S1产线自正式投产以来,产能结合销售需求逐步释放
证券之星 · 03-10
浙江震元:公司合成生物S1产线自正式投产以来,产能结合销售需求逐步释放
股市必读:浙江震元(000705)1月23日董秘有最新回复
证券之星 · 01-26
股市必读:浙江震元(000705)1月23日董秘有最新回复
浙江震元:未投资箭元科技
证券之星 · 01-23
浙江震元:未投资箭元科技
浙江震元:S2生产线计划今年投产
证券之星 · 01-22
浙江震元:S2生产线计划今年投产
股市必读:浙江震元(000705)1月20日董秘有最新回复
证券之星 · 01-21
股市必读:浙江震元(000705)1月20日董秘有最新回复
浙江震元:组氨酸产品已投放市场反应良好
证券之星 · 01-20
浙江震元:组氨酸产品已投放市场反应良好
浙江震元:S1生产线产销情况良好
证券之星 · 01-08
浙江震元:S1生产线产销情况良好
股市必读:浙江震元(000705)12月30日董秘有最新回复
证券之星 · 2025-12-31
股市必读:浙江震元(000705)12月30日董秘有最新回复
浙江震元:S2生产线计划2026年投产
证券之星 · 2025-12-09
浙江震元:S2生产线计划2026年投产
浙江震元:S2生产线计划2026年投产
证券之星 · 2025-12-05
浙江震元:S2生产线计划2026年投产
浙江震元:S1产线可生产水溶性氨基酸产品
证券之星 · 2025-11-21
浙江震元:S1产线可生产水溶性氨基酸产品
股市必读:浙江震元(000705)11月14日董秘有最新回复
证券之星 · 2025-11-17
股市必读:浙江震元(000705)11月14日董秘有最新回复
加载更多
公司概况
公司名称:
浙江震元股份有限公司
所属行业:
批发业
上市日期:
1997-04-10
主营业务:
浙江震元股份有限公司的主营业务是医药流通、医药工业、中药饮片和健康产品及服务。公司的主要产品是中药材、中药饮片、中成药、化学原料药、化学药制剂、抗生素、生化药品、生物制品、医疗器械、化学试剂、玻璃仪器。报告期内,震元连锁斩获多项殊荣,包括浙江省服务业领军企业、西湖奖中国医药零售成长力企业等。
发行价格:
4.45
{"stockData":{"symbol":"000705","market":"SZ","secType":"STK","nameCN":"浙江震元","latestPrice":8.69,"timestamp":1777273395000,"preClose":8.6,"halted":0,"volume":4665160,"delay":0,"changeRate":0.0105,"floatShares":282000000,"shares":334000000,"eps":0.1414,"marketStatus":"已收盘","change":0.09,"latestTime":"04-27 15:00:00","open":8.58,"high":8.77,"low":8.51,"amount":40218700,"amplitude":0.0302,"askPrice":8.69,"askSize":205,"bidPrice":8.68,"bidSize":64,"shortable":0,"etf":0,"ttmEps":0.1414,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777339800000},"marketStatusCode":5,"adr":0,"adjPreClose":8.6,"symbolType":"stock","openAndCloseTimeList":[[1777253400000,1777260600000],[1777266000000,1777273200000]],"highLimit":9.46,"lowLimit":7.74,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":334123286,"isCdr":false,"pbRate":1.42,"roa":"--","peRate":61.45686,"roe":"2.82%","epsLYR":0.1,"committee":-0.696682,"marketValue":2904000000,"turnoverRate":0.0165,"status":0,"floatMarketCap":2450000000},"requestUrl":"/m/hq/s/000705","defaultTab":"news","newsList":[{"id":"2629901062","title":"浙江震元:震元生物结合销售需求正常生产中","url":"https://stock-news.laohu8.com/highlight/detail?id=2629901062","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629901062?lang=zh_cn&edition=full","pubTime":"2026-04-22 08:49","pubTimestamp":1776818947,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)04月21日在投资者关系平台上答复投资者关心的问题。投资者提问:您好,1,咨询震元生物26年第一季度产线是否在连续生产,定单饱满度以及对一季度利润的贡献。浙江震元回复:您好,感谢您的提问。震元生物结合销售需求正常生产中。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200016089.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628201819","title":"浙江震元最新公告:董事、副总经理魏民被留置调查","url":"https://stock-news.laohu8.com/highlight/detail?id=2628201819","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628201819?lang=zh_cn&edition=full","pubTime":"2026-04-17 20:59","pubTimestamp":1776430778,"startTime":"0","endTime":"0","summary":"浙江震元(000705.SZ)公告称,公司于2026年4月16日收到监察机关《留置通知书》和《立案通知书》,公司董事、副总经理魏民被立案调查并实施留置措施。截至公告披露日,公司已对魏民负责的相关工作进行妥善安排,董事及其他高级管理人员均正常履职,公司生产经营情况正常,未受影响。目前,公司尚未知悉调查的进展及结论。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700043474.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627268262","title":"浙江震元:公司S1产线的产品国内目前使用客户有医美、食品等行业","url":"https://stock-news.laohu8.com/highlight/detail?id=2627268262","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627268262?lang=zh_cn&edition=full","pubTime":"2026-04-16 11:33","pubTimestamp":1776310394,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)04月15日在投资者关系平台上答复投资者关心的问题。投资者提问:公司s1产线的产品国内客户主要是食品行业的还是医药公司多些,海外客户是亚洲还是欧洲的浙江震元回复:您好,感谢您的提问。公司S1产线的产品国内目前使用客户有医美、食品等行业,海外市场积极开发中。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600017513.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250","159151"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623390953","title":"浙江震元:华润震元自2025年2月起不再纳入公司合并财务报表范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2623390953","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623390953?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:42","pubTimestamp":1774860136,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元03月30日在投资者关系平台上答复投资者关心的问题。2025年1月26日,原公司全资子公司绍兴震元医药经营有限责任公司完成增资扩股工商变更登记,更名为华润震元医药(浙江)有限公司。变更后,华润医药商业集团有限公司持有华润震元51%股权,公司持有华润震元49%股权,华润震元自2025年2月起不再纳入公司合并财务报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000022007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622285070","title":"浙江震元:公司合成生物S1产线自正式投产以来,产能结合销售需求逐步释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2622285070","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622285070?lang=zh_cn&edition=full","pubTime":"2026-03-25 15:30","pubTimestamp":1774423849,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)03月24日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的公司领导,您好,目前合成生物S1去年8月份已经投产,请问目前市场反应如何?订单情况如何,毛率利大概多少?S2C产线是否已经试运行?原料药集聚提升项目进度如何7月份是否能如期投产,谢谢。浙江震元回复:您好,感谢您的提问。公司合成生物S1产线自正式投产以来,产能结合销售需求逐步释放。S2产线及原料药集聚提升项目正常建设推进中。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032500023988.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621860540","title":"股市必读:浙江震元(000705)3月23日收盘跌7.1%,主力净流出705.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621860540","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621860540?lang=zh_cn&edition=full","pubTime":"2026-03-24 03:00","pubTimestamp":1774292442,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,浙江震元报收于8.11元,下跌7.1%,换手率3.37%,成交量9.51万手,成交额7899.98万元。交易信息汇总股价提醒3月23日浙江震元收盘报8.11元,跌7.1%,当日成交951.26万元。根据收盘数据统计,该股已连续3日下跌。前10个交易日资金流向情况:主力资金累计净流出1262.21万元,股价累计下跌10.69% 资金流向3月23日主力资金净流出705.19万元;游资资金净流入774.25万元;散户资金净流出69.05万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619100778","title":"股市必读:浙江震元(000705)3月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2619100778","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619100778?lang=zh_cn&edition=full","pubTime":"2026-03-16 02:36","pubTimestamp":1773599772,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,浙江震元报收于9.17元,上涨1.1%,换手率2.72%,成交量7.67万手,成交额7013.93万元。董秘最新回复投资者: 尊敬的公司领导,目前公司合成生物生产组氨酸相对于竞品来说有哪些优势,相对于竞品来说生产成本下降百分之几?公司以技术创新为动,通过自身的技术优势和核心竞争力,持续提升产品市场增量。当日关注点来自交易信息汇总:3月13日主力资金净流入517.22万元,显示主力对个股呈积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600000985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618968179","title":"股市必读:浙江震元(000705)3月10日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2618968179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618968179?lang=zh_cn&edition=full","pubTime":"2026-03-11 01:59","pubTimestamp":1773165548,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘,浙江震元报收于9.19元,上涨1.21%,换手率1.31%,成交量3.71万手,成交额3394.44万元。公司合成生物S1产线自正式投产以来,产能结合销售需求逐步释放。S2产线及原料药集聚提升项目正常建设推进中。当日关注点来自交易信息汇总:3月10日主力资金净流入353.22万元,呈现主力积极介入态势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100000928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618338709","title":"浙江震元:公司合成生物S1产线自正式投产以来,产能结合销售需求逐步释放","url":"https://stock-news.laohu8.com/highlight/detail?id=2618338709","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618338709?lang=zh_cn&edition=full","pubTime":"2026-03-10 17:00","pubTimestamp":1773133232,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元03月10日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的公司领导,您好,2026年是是公司战略调整重要的一年,从2025年8月份合成生物项目S1产线的投产,目前投产已经差不多半年,当前产能释放如何?公司合成生物S1产线自正式投产以来,产能结合销售需求逐步释放。S2产线及原料药集聚提升项目正常建设推进中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000025610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606265960","title":"股市必读:浙江震元(000705)1月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2606265960","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606265960?lang=zh_cn&edition=full","pubTime":"2026-01-26 03:17","pubTimestamp":1769368630,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘,浙江震元报收于9.68元,上涨1.15%,换手率2.93%,成交量8.27万手,成交额7989.01万元。董秘最新回复投资者: 核实公司投资的绍兴普华震元创业投资合伙企业是否间接投资了火箭发射及回收企业“箭元科技”。当日关注点来自交易信息汇总:1月23日主力资金净流入250.03万元,显示主力对个股短期关注度提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605420844","title":"浙江震元:未投资箭元科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2605420844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605420844?lang=zh_cn&edition=full","pubTime":"2026-01-23 16:12","pubTimestamp":1769155935,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)01月23日在投资者关系平台上答复投资者关心的问题。投资者提问:核实公司投资的绍兴普华震元创业投资合伙企业是否间接投资了火箭发射及回收企业“箭元科技”。浙江震元回复:您好,感谢您的提问。公司投资的绍兴普华震元创业投资合伙企业(有限合伙)未投资火箭发射及回收企业“箭元科技”。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300022020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605043785","title":"浙江震元:S2生产线计划今年投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2605043785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605043785?lang=zh_cn&edition=full","pubTime":"2026-01-22 08:51","pubTimestamp":1769043069,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)01月21日在投资者关系平台上答复投资者关心的问题。投资者提问:贵公司打算投资新建几条生产线?浙江震元回复:您好,感谢您的提问。公司S2生产线计划今年投产,暂未规划其他生产线。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200006336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605614305","title":"股市必读:浙江震元(000705)1月20日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605614305","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605614305?lang=zh_cn&edition=full","pubTime":"2026-01-21 02:46","pubTimestamp":1768934770,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘,浙江震元报收于9.43元,上涨0.32%,换手率2.12%,成交量5.97万手,成交额5609.07万元。公司下属子公司浙江震元生物科技有限公司采用合成生物技术生产小品种氨基酸,目前正式投放市场的产品为组氨酸及盐酸组氨酸,市场反应良好。S2生产线计划今年投产。今后公司将根据研发进展及市场需求情况陆续投入其他氨基酸产品的生产与销售。当日关注点来自交易信息汇总:1月20日主力资金净流出549.47万元,散户资金净流入589.61万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100001178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604162138","title":"浙江震元:组氨酸产品已投放市场反应良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2604162138","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604162138?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:06","pubTimestamp":1768892784,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元01月20日在投资者关系平台上答复投资者关心的问题。公司下属子公司浙江震元生物科技有限公司采用合成生物技术生产小品种氨基酸,目前正式投放市场的产品为组氨酸及盐酸组氨酸,市场反应良好。S2生产线计划今年投产。今后公司将根据研发进展及市场需求情况陆续投入其他氨基酸产品的生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000018039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000705","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601338634","title":"浙江震元:S1生产线产销情况良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2601338634","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601338634?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:55","pubTimestamp":1767833709,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元01月07日在投资者关系平台上答复投资者关心的问题。投资者提问:请问:S1生产线已经投产一个季度,S2生产线正在调试,企业向生物制造行业正在转型,想了解一下S1生产线共计投入多少?四季度产能达产多少?能贡献利润多少?公司生物定向合成项目预计总投资58,704.37万元。S1生产线结合市场需求逐步释放产能,产销情况良好。S2生产线按工程进度安排推进中,计划2026年投产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800006227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595712705","title":"股市必读:浙江震元(000705)12月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2595712705","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595712705?lang=zh_cn&edition=full","pubTime":"2025-12-31 04:37","pubTimestamp":1767127029,"startTime":"0","endTime":"0","summary":"截至2025年12月30日收盘,浙江震元报收于9.05元,下跌0.33%,换手率2.37%,成交量6.68万手,成交额6053.59万元。董秘最新回复投资者: 麻烦公司S1生产线投产对公司利润是否有较大的正方向影响?公司组氨酸自投产以来,结合市场需求安排生产计划,产销情况良好。交易信息汇总资金流向12月30日主力资金净流入271.19万元;游资资金净流入726.02万元;散户资金净流出997.22万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100004670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590318082","title":"浙江震元:S2生产线计划2026年投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2590318082","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590318082?lang=zh_cn&edition=full","pubTime":"2025-12-09 15:21","pubTimestamp":1765264883,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元12月09日在投资者关系平台上答复投资者关心的问题。投资者提问:问S2、S3、S4生产线什么时候投产?公司S2生产线按工程进度安排推进中,计划2026年投产。26年1月和12月也是26年,作为公司要将投资者的疑问和关注用最直接的语言作回答,例如26年1月投产或2月或3月,计划2026年投产的回答是很不专业的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900018313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589867165","title":"浙江震元:S2生产线计划2026年投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2589867165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589867165?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:24","pubTimestamp":1764923064,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问:S2、S3、S4生产线什么时候投产?我们投资者是要一个确定的投产时间,而不是让我们靠猜靠估。浙江震元回复:您好,感谢您的关注。公司S2生产线按工程进度安排推进中,计划2026年投产。公司未规划S3、S4生产线。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500021600.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585193936","title":"浙江震元:S1产线可生产水溶性氨基酸产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2585193936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585193936?lang=zh_cn&edition=full","pubTime":"2025-11-21 11:36","pubTimestamp":1763696208,"startTime":"0","endTime":"0","summary":"证券之星消息,浙江震元(000705)11月21日在投资者关系平台上答复投资者关心的问题。投资者提问:尊敬的董秘你好,目前合成生物S1产线已经正式投产,之前回复投资者说一条产线可以生产多个产品,想了解一下目前S1产线能生产那些产品。浙江震元回复:您好,感谢您的提问。公司S1产线可以生产不同品种的水溶性氨基酸产品,公司将按照研发进展有序推进其他氨基酸产品的生产。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100012828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584698590","title":"股市必读:浙江震元(000705)11月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584698590","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584698590?lang=zh_cn&edition=full","pubTime":"2025-11-17 01:44","pubTimestamp":1763315054,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,浙江震元报收于10.34元,上涨2.27%,换手率9.07%,成交量25.58万手,成交额2.65亿元。董秘最新回复投资者: 亲爱的董秘,您好!请问震元生物合成生物项目是否已经量产?有哪些潜在的意向客户?合成生物S1产线已投产,结合市场需求逐步释放产能。交易信息汇总资金流向11月14日主力资金净流入1931.56万元,占总成交额7.29%;游资资金净流入73.97万元,占总成交额0.28%;散户资金净流出2005.53万元,占总成交额7.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700000654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000705"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777276579764,"stockEarnings":[{"period":"1week","weight":-0.0227},{"period":"1month","weight":-0.0035},{"period":"3month","weight":-0.1116},{"period":"6month","weight":-0.1224},{"period":"1year","weight":0.1191},{"period":"ytd","weight":-0.0497}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0377},{"period":"3month","weight":-0.0136},{"period":"6month","weight":0.0328},{"period":"1year","weight":0.2374},{"period":"ytd","weight":0.028}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江震元股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"35792人(较上一季度增加17.24%)","perCapita":"7877股","listingDate":"1997-04-10","address":"浙江省绍兴市越城区稽山街道延安东路558号","registeredCapital":"33412万元","survey":" 浙江震元股份有限公司的主营业务是医药流通、医药工业、中药饮片和健康产品及服务。公司的主要产品是中药材、中药饮片、中成药、化学原料药、化学药制剂、抗生素、生化药品、生物制品、医疗器械、化学试剂、玻璃仪器。报告期内,震元连锁斩获多项殊荣,包括浙江省服务业领军企业、西湖奖中国医药零售成长力企业等。","listedPrice":4.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"浙江震元(000705)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供浙江震元(000705)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"浙江震元,000705,浙江震元股票,浙江震元股票老虎,浙江震元股票老虎国际,浙江震元行情,浙江震元股票行情,浙江震元股价,浙江震元股市,浙江震元股票价格,浙江震元股票交易,浙江震元股票购买,浙江震元股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"浙江震元(000705)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供浙江震元(000705)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}